2010
DOI: 10.1016/j.ccr.2010.10.019 View full text |Buy / Rent full text
|
|

Abstract: mTORC1 is a validated therapeutic target for renal cell carcinoma (RCC). Here, analysis of Tsc1 deficient (mTORC1 hyperactivation) mice uncovered a FoxO-dependent negative feedback circuit constraining mTORC1-mediated renal tumorigenesis. We document robust FoxO activation in Tsc1 deficient benign polycystic kidneys and FoxO extinction upon progression to murine renal tumors; murine renal tumor progression upon genetic deletion of both Tsc1 and FoxOs; and down-regulated FoxO expression in most human renal clea… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
8
108
0

Publication Types

Select...

Relationship

0
0

Authors

Journals